$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000162828019006430 Filed on May 09, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q4
Revenue	$26.75M	$21.78M	$22.02M
YoY Change	1516.5%	1271.47%	60.01%
Cost Of Revenue	$55.00K	$131.0K	$160.0K
YoY Change	-52.59%	-35.47%	-65.96%
Gross Profit	$26.70M	$21.65M	$21.86M
YoY Change	1634.76%	1463.03%	64.48%
Gross Profit Margin	99.79%	99.4%	99.29%
Selling, General & Admin	$16.93M	$14.63M	$14.89M
YoY Change	32.89%	33.85%	23.77%
% of Gross Profit	63.41%	67.58%	68.12%
Research & Development	$19.11M	$26.26M	$25.45M
YoY Change	-1.57%	44.74%	65.37%
% of Gross Profit	71.57%	121.28%	116.42%
Depreciation & Amortization	$450.0K	$380.0K	$310.0K
YoY Change	114.29%	72.73%	82.35%
% of Gross Profit	1.69%	1.76%	1.42%
Operating Expenses	$19.11M	$41.02M	$40.49M
YoY Change	-40.79%	40.1%	45.23%
Operating Profit	-$9.338M	-$19.24M	-$18.47M
YoY Change	-69.5%	-30.52%	30.83%
Interest Expense	$5.530M	$5.600M	-$5.150M
YoY Change	50.44%	98.23%	80.07%
% of Operating Profit
Other Income/Expense, Net	$415.0K	$494.0K	$150.0K
YoY Change	-30.49%	7.39%	-65.12%
Pretax Income	-$14.45M	-$24.35M	-$36.46M
YoY Change	-57.12%	-18.97%	120.3%
Income Tax			-$12.93M
% Of Pretax Income
Net Earnings	-$14.45M	-$24.35M	-$23.53M
YoY Change	-57.11%	-19.0%	42.19%
Net Earnings / Revenue	-54.02%	-111.78%	-106.89%
Basic Earnings Per Share
Diluted Earnings Per Share	-$294.4K	-$496.8K	-$480.0K
COMMON SHARES
Basic Shares Outstanding	49.06M shares	49.01M shares	49.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.80M	$47.20M	$60.50M
YoY Change	-64.03%	-35.16%	-27.72%
Cash & Equivalents	$4.000M	$4.054M	$5.900M
Short-Term Investments	$27.90M	$43.20M	$54.60M
Other Short-Term Assets	$4.400M	$4.200M	$6.500M
YoY Change	-30.16%	-22.22%	-7.14%
Inventory	$1.187M	$736.0K	$88.00K
Prepaid Expenses			$6.463M
Receivables	$28.40M	$24.60M	$22.70M
Other Receivables	$134.0K	$138.0K	$164.0K
Total Short-Term Assets	$65.94M	$76.87M	$89.87M
YoY Change	-31.67%	-2.3%	-17.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.183M	$4.479M	$3.845M
YoY Change	71.72%	115.23%	81.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.300M	$2.400M	$2.200M
YoY Change	-68.92%	-71.08%	-62.07%
Total Long-Term Assets	$23.82M	$24.38M	$6.069M
YoY Change	141.91%	135.48%	-23.72%
TOTAL ASSETS
Total Short-Term Assets	$65.94M	$76.87M	$89.87M
Total Long-Term Assets	$23.82M	$24.38M	$6.069M
Total Assets	$89.76M	$101.2M	$95.94M
YoY Change	-15.6%	13.71%	-17.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.260M	$7.121M	$6.281M
YoY Change	-47.17%	-30.07%	-6.13%
Accrued Expenses	$31.78M	$34.82M	$30.19M
YoY Change	165.16%	149.91%	57.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.100M	$2.561M	$889.0K
YoY Change	80.92%	399.22%	81.43%
Total Short-Term Liabilities	$40.67M	$44.51M	$37.36M
YoY Change	66.41%	80.69%	42.0%
LONG-TERM LIABILITIES
Long-Term Debt	$155.1M	$153.1M	$150.6M
YoY Change	19.54%	80.04%	79.04%
Other Long-Term Liabilities	$24.30M	$24.70M	$8.200M
YoY Change	185.88%	187.21%	-5.75%
Total Long-Term Liabilities	$179.4M	$177.8M	$158.8M
YoY Change	38.27%	109.09%	88.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.67M	$44.51M	$37.36M
Total Long-Term Liabilities	$179.4M	$177.8M	$158.8M
Total Liabilities	$220.0M	$222.3M	$196.1M
YoY Change	42.68%	102.7%	77.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$688.9M	-$674.5M	-$650.1M
YoY Change	17.34%	21.87%	24.22%
Common Stock	$558.6M	$490.0K	$550.0M
YoY Change	115085.36%	1.45%	114001.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$130.3M	-$121.0M	-$100.2M
YoY Change
Total Liabilities & Shareholders Equity	$89.76M	$101.2M	$95.94M
YoY Change	-15.6%	13.71%	-17.53%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q4
OPERATING ACTIVITIES
Net Income	-$14.45M	-$24.35M	-$23.53M
YoY Change	-57.11%	-19.0%	42.19%
Depreciation, Depletion And Amortization	$450.0K	$380.0K	$310.0K
YoY Change	114.29%	72.73%	82.35%
Cash From Operating Activities	-$16.59M	-$12.95M	-$24.66M
YoY Change	-46.33%	14.62%	491.37%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	$182.0K	-$100.0K
YoY Change	-52.38%	-0.55%
Acquisitions
YoY Change
Other Investing Activities	$15.31M	$11.47M	-$2.270M
YoY Change	-210.14%	31.39%	-141.8%
Cash From Investing Activities	$15.21M	$11.29M	-$2.360M
YoY Change	-207.87%	32.06%	-143.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.310M	-146.0K	30.09M
YoY Change	-97.2%	-126.84%	2610.81%
NET CHANGE
Cash From Operating Activities	-16.59M	-12.95M	-24.66M
Cash From Investing Activities	15.21M	11.29M	-2.360M
Cash From Financing Activities	1.310M	-146.0K	30.09M
Net Change In Cash	-70.00K	-1.807M	3.070M
YoY Change	-104.12%	-18.05%	29.54%
FREE CASH FLOW
Cash From Operating Activities	-$16.59M	-$12.95M	-$24.66M
Capital Expenditures	-$100.0K	$182.0K	-$100.0K
Free Cash Flow	-$16.49M	-$13.13M	-$24.56M
YoY Change	-46.29%	14.38%	488.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001285819
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49057866	shares
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	OMEROS CORP
CY2019Q1	dei	Trading Symbol TradingSymbol	OMER
CY2018Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	820000	USD
CY2019Q1	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	913000	USD
CY2018Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	12012000	USD
CY2019Q1	omer	Accrued Contract Research Costs AccruedContractResearchCosts	14460000	USD
CY2018Q4	omer	Advanced Payments Noncurrent AdvancedPaymentsNoncurrent	1070000	USD
CY2019Q1	omer	Advanced Payments Noncurrent AdvancedPaymentsNoncurrent	1228000	USD
CY2018Q2	omer	Classof Warrantor Right Period ClassofWarrantorRightPeriod	P5Y
CY2019Q1	omer	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2019Q1	omer	Lease Liability LeaseLiability	29139000	USD
CY2019Q1	omer	Lease Rightof Use Asset LeaseRightofUseAsset	20927000	USD
CY2018Q4	omer	Leaseliabilitiesnoncurrent Leaseliabilitiesnoncurrent	1578000	USD
CY2019Q1	omer	Leaseliabilitiesnoncurrent Leaseliabilitiesnoncurrent	26578000	USD
CY2019Q1	omer	Lessee Operating Lease Lease Notyet Commenced.Amount LesseeOperatingLeaseLeaseNotyetCommenced.Amount	100000	USD
CY2019Q1	omer	Lessee Operating Lease Lease Notyet Commenced Termof Contract1 LesseeOperatingLeaseLeaseNotyetCommencedTermofContract1	P7Y
CY2019Q1	omer	Lessee Operating Lease Termof Contract1 LesseeOperatingLeaseTermofContract1	P5Y
CY2019Q1	omer	Long Term Purchase Commitment Termination Fee LongTermPurchaseCommitmentTerminationFee	13700000	USD
CY2018Q1	omer	Noncash Transaction Conversion Of Accrued Interest Into Notes Payable NoncashTransactionConversionOfAccruedInterestIntoNotesPayable	838000	USD
CY2019Q1	omer	Noncash Transaction Conversion Of Accrued Interest Into Notes Payable NoncashTransactionConversionOfAccruedInterestIntoNotesPayable	0	USD
CY2019Q1	omer	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7M6D
CY2018Q1	omer	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	687000	USD
CY2019Q1	omer	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	108000	USD
CY2019Q1	omer	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumber	4025231	shares
CY2019Q1	omer	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	10744	shares
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6281000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7121000	USD
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	22654000	USD
CY2019Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	24580000	USD
CY2018Q4	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent	8075000	USD
CY2019Q1	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent	8161000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30186000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34823000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3669000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3344000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4245000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4622000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	549479000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	552961000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9741054	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12083636	shares
CY2018Q4	us-gaap	Assets Assets	95936000	USD
CY2019Q1	us-gaap	Assets Assets	101246000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	89867000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	76871000	USD
CY2018Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	54637000	USD
CY2019Q1	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	43168000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3394000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1189000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5861000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5900000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4054000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2205000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1807000	USD
CY2018Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	23.00
CY2018Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	200000	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49011684	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49022428	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49011684	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49022428	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	490000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	490000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30054000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24345000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	203000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	131000	USD
CY2019Q1	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	400000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8177000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	223000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	377000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.50
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2714000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2233000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	15600000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P9Y1M6D
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	82000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	82000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3041000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1146000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1895000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3535000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1060000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	95000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	290000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	866000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1224000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	494000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	254000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3413000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	290000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1231
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10934000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14632000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1835000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5883000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-196000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	648000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	840000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2110000	USD
CY2018Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-16962000	USD
CY2019Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1900000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	2825000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	5600000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	1739000	USD
CY2019Q1	us-gaap	Interest Paid InterestPaid	82000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1677000	USD
CY2019Q1	us-gaap	Interest Payable Current InterestPayableCurrent	4995000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	301000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	88000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	736000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	83000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	43000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	392000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	1803000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	43984000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	20728000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5112000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4995000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4880000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4770000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3499000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17886000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95936000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101246000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37356000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	44505000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	889000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2561000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	544000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-146000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8547000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11287000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11296000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12948000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-30054000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-24345000	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	29277000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	41018000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27689000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19239000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1031000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	26098000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1415000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24683000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1647000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17514000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17514000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1285
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1219000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	717000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	460000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	494000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164000	USD
CY2019Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	138000	USD
CY2018Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1086000	USD
CY2019Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	2201000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	270000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	281000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	183000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	182000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6463000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4195000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	9000000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	11750000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8090000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9101000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3845000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4479000	USD
CY2018Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	22818000	USD
CY2019Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	24718000	USD
CY2018Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	143000	USD
CY2019Q1	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	254000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18140000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26255000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1154000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1154000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-650125000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-674470000	USD
CY2018Q1	us-gaap	Revenues Revenues	1588000	USD
CY2019Q1	us-gaap	Revenues Revenues	21779000	USD
CY2018Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	148981000	USD
CY2019Q1	us-gaap	Senior Long Term Notes SeniorLongTermNotes	151182000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2966000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3374000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	554083	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7815290	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.31
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	68373	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	14.67
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1606500	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	71857	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10313138	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11840521	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.22
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.51
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	70182	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	11402367	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.41
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.01
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.49
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	56232	USD
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M6D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M13D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y6M12D
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	138000	USD
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10744	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-100156000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-121019000	USD
CY2019Q1	us-gaap	Sublease Income SubleaseIncome	224000	USD
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	486000	USD
CY2018Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1400000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48284019	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49014009	shares
CY2019Q1	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Sales, Net</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generally record revenue from product sales when the product is delivered to our wholesalers. Product sales are recorded net of wholesaler distribution fees and estimated chargebacks, rebates, returns and purchase-volume discounts. Accruals or allowances are established for these deductions in the same period when revenue is recognized, and actual amounts incurred are offset against the applicable accruals or allowances. We reflect each of these accruals or allowances as either a reduction in the related accounts receivable or as an accrued liability depending on how the amount is expected to be settled.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-006430-index-headers.html	Edgar Link	pending
0001628280-19-006430-index.html	Edgar Link	pending
0001628280-19-006430.txt	Edgar Link	pending
0001628280-19-006430-xbrl.zip	Edgar Link	pending
chart-5e95a9d683382968ea8a02.jpg	Edgar Link	pending
ex311_20190331.htm	Edgar Link	pending
ex312_20190331.htm	Edgar Link	pending
ex321_20190331.htm	Edgar Link	pending
ex322_20190331.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
omer-20190331.xml	Edgar Link	completed
omer-20190331.xsd	Edgar Link	pending
omer-20190331x10q.htm	Edgar Link	pending
omer-20190331_cal.xml	Edgar Link	unprocessable
omer-20190331_def.xml	Edgar Link	unprocessable
omer-20190331_lab.xml	Edgar Link	unprocessable
omer-20190331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2019 Q2 Form 10-Q Financial Statement

#000162828019006430 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2019 Q2 Form 10-Q Financial Statement

#000162828019006430 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer